To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Liver cancer
Cell culture studies suggest inhibiting PDE3A, FYB1, BICC1 or PURPL
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury